SCHEMBL9060705

SCHEMBL9060705

Cc1nnc(-c2cccc(-c3ccc(C(=O)O)cc3C)c2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.51
MAP2K1 Q02750 2/20 0.51
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KMT2A Q03164 1/20 0.49
RARA P10276 1/20 0.48
RARB P10826 1/20 0.48
RARG P13631 1/20 0.48
MYC P01106 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
NR1H4 Q96RI1 1/20 0.45
MAPK11 Q15759 1/20 0.44
LCK P06239 1/20 0.43
CSF1R P07333 1/20 0.43
KDR P35968 1/20 0.43
RORC P51449 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7829646 0.88 MAPK14 (0.63) MAPK14MAP2K1NPC1RAB9AKMT2A
SCHEMBL7832639 0.87 RARB (0.56) MAPK14MAP2K1NPC1RAB9ARARA
SCHEMBL7448719 0.85 MAPK14 (0.57) MAPK14MAP2K1NPC1RAB9AKMT2A
SCHEMBL16572042 0.85 MYC (0.61) MAPK14NPC1RAB9AKMT2AMYC
SCHEMBL31658246 0.83 AKR1C3 (0.61) KMT2ARARBMYCAKR1C3AKR1C2
SCHEMBL8171164 0.82 RARA (0.54) MAPK14MAP2K1NPC1RAB9AKMT2A
SCHEMBL5123466 0.82 MAPK14 (0.72) MAPK14MAP2K1RARARARBRARG
SCHEMBL6252539 0.79 AKR1C3 (0.68) RARBAKR1C3AKR1C2NR1H4KDM4E
SCHEMBL23752303 0.78 MAPK14 (0.75) MAPK14MAP2K1NPC1RAB9ALCK
SCHEMBL5659598 0.77 MAPK14 (0.67) MAPK14MAP2K1NPC1RAB9ARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996019477-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed